Gene patents face Supreme Court reckoning

Supreme Court of the United States

Medical-testing companies differ on the potential impact of the Supreme Court ruling on the Myriad Genetics BRCA1 patent. Many companies offer a range of tests. Figuring out who owns the rights to all those genes isn’t easy.

View the original article here: Gene Patents Face Reckoning

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.